These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 895073)
1. Is the stage set for lymphoid tissue replacement in active lepromatous leprosy patients? Talwar GP Lepr India; 1977 Jan; 49(1):1-5. PubMed ID: 895073 [No Abstract] [Full Text] [Related]
2. Immunological aspects of experimental leprosy in the mouse. Rees RJ Proc R Soc Med; 1970 Oct; 63(10):1060-2. PubMed ID: 5483517 [No Abstract] [Full Text] [Related]
3. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration. Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597 [TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of leprosy in 1981]. Wallach D Acta Leprol; 1982; (86-87):165-76. PubMed ID: 6815984 [No Abstract] [Full Text] [Related]
5. Comparative study of the 48-hour response to soluble antigens obtained from human and armadillo leprosy material in lepromatous leprosy patients and normal persons, contacts of leprosy patients. Convit J; Pinardi ME; Aranzazu N Int J Lepr Other Mycobact Dis; 1976; 44(1-2):284-6. PubMed ID: 945241 [TBL] [Abstract][Full Text] [Related]
7. Normal lymphocyte transfer tests in leprosy. Saha K; Mittal MM Clin Exp Immunol; 1970 Jun; 6(6):969-74. PubMed ID: 5477731 [TBL] [Abstract][Full Text] [Related]
8. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients. Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181 [TBL] [Abstract][Full Text] [Related]
9. A study of cell mediated immunity in leprosy: changing trends in the immunological spectrum of the disease. Saha K; Mittal MM Clin Exp Immunol; 1971 Jun; 8(6):901-9. PubMed ID: 5091616 [TBL] [Abstract][Full Text] [Related]
10. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy. Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953 [TBL] [Abstract][Full Text] [Related]
11. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy. Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762 [TBL] [Abstract][Full Text] [Related]
12. Reactions to antigens from actinomycetes including Mycobacterium leprae in leprosy patients. Ohman R; Walford C; Converse P; Ridell M Int J Lepr Other Mycobact Dis; 1991 Jun; 59(2):320-2. PubMed ID: 2071990 [No Abstract] [Full Text] [Related]
13. The lymphoid apparatus of the sheep: its growth, development and significance in immunologic reactions. Cole GJ; Morris B Adv Vet Sci Comp Med; 1973; 17():225-63. PubMed ID: 4593801 [No Abstract] [Full Text] [Related]
14. Determination of circulating IgG subclasses against lipoarabinomannan in the leprosy spectrum and reactions. Beuria MK; Mohanty KK; Katoch K; Sengupta U Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4):422-8. PubMed ID: 10700917 [TBL] [Abstract][Full Text] [Related]
15. Serum antibodies to defined carbohydrate antigens during the course of treated leprosy. Gelber RH; Li F; Cho SN; Byrd S; Rajagopalan K; Brennan PJ Int J Lepr Other Mycobact Dis; 1989 Dec; 57(4):744-51. PubMed ID: 2681457 [TBL] [Abstract][Full Text] [Related]